Authors:
Steinmetz, HT
Schulz, A
Staib, P
Scheid, C
Glasmacher, A
Neufang, A
Franklin, J
Tesch, H
Diehl, V
Wickramanayake, PD
Citation: Ht. Steinmetz et al., Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML, ANN HEMATOL, 78(9), 1999, pp. 418-425